BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 4419263)

  • 21. [Clinical evaluation of lyndiol novem, a modernized hormonal contraceptive].
    Göran C
    Opusc Med; 1973; 18(4):180-2. PubMed ID: 4614998
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hypertension and oral contraceptives].
    Kjaer M; Petersen JL
    Ugeskr Laeger; 1971 Jun; 133(22):1082-4. PubMed ID: 5556612
    [No Abstract]   [Full Text] [Related]  

  • 23. [Oral contraceptives and venous and arterial thromboembolic manifestations. Apropos of 4 cases].
    Sternon J; Franken L; De Coster A
    Acta Cardiol; 1968; 23(3):263-72. PubMed ID: 5303319
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical studies on oral contraceptives--a randomized, doubleblind, crossover study of 4 different preparations (Anovlar mite, Lyndiol mite, Ovulen, and Volidan).
    Nilsson L; Sölvell L
    Acta Obstet Gynecol Scand; 1967; 46(S8):3-31. PubMed ID: 4229036
    [No Abstract]   [Full Text] [Related]  

  • 25. [Thrombelastography and oral contraceptives].
    Delacrétaz-Dubugnon F
    Schweiz Med Wochenschr; 1972 Jan; 102(2):48-52. PubMed ID: 4644685
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hormonal treatment of juvenile menstruation disorders].
    Sas M
    Fortschr Med; 1974 May; 92(15):641-2. PubMed ID: 4829461
    [No Abstract]   [Full Text] [Related]  

  • 27. Amenorrhoea following oral contraception.
    Starup J
    Acta Obstet Gynecol Scand; 1972; 51(4):341-5. PubMed ID: 4642722
    [No Abstract]   [Full Text] [Related]  

  • 28. [The search for new ways with low dose contraceptives. II].
    Tóth F; Gimes R; Horn B; Kerényi T
    Z Arztl Fortbild (Jena); 1972 Oct; 66(20):1021-5. PubMed ID: 4651027
    [No Abstract]   [Full Text] [Related]  

  • 29. [Blood coagulation and fibrinolysis in patients treated with an anovulatory drug with estroprogestational action].
    Schubert L; Gibelli A; De Nicola P
    Ann Ostet Ginecol Med Perinat; 1968 Jan; 90(1):48-58. PubMed ID: 5739142
    [No Abstract]   [Full Text] [Related]  

  • 30. Preliminary experience with a new low-oestrogen content combined oral contraceptive.
    Prsić J; Kićović PM
    Curr Med Res Opin; 1974; 2(4):204-10. PubMed ID: 4841307
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of steroidal antifertility agents after two to six years of continuous use.
    Rice-Wray E; Cervantes A; Gastelum H
    Int J Fertil; 1967; 12(3):312-9. PubMed ID: 4166548
    [No Abstract]   [Full Text] [Related]  

  • 32. [A case of jaundice due to oral contraceptives].
    Dal Monte PR; Sarti F; Toscano S; Pasotto A
    G Clin Med; 1972 Mar; 53(3):111-20. PubMed ID: 4649401
    [No Abstract]   [Full Text] [Related]  

  • 33. [The therapeutic use of the sequentially administered oral ovulation inhibitor Ovanon].
    Gimes R; Tóth F
    Dtsch Med J; 1969 Dec; 20(23):718-9. PubMed ID: 5397037
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of dysfunctional uterine hemorrhages and amenorrheas using a progestagen-estrogen combination].
    Brehm H; Karsznia R; Prinz W; Schmidt G
    Med Monatsschr; 1972 Dec; 26(12):577-9. PubMed ID: 4663633
    [No Abstract]   [Full Text] [Related]  

  • 35. [In vivo studies on metabolism of androgens following administration of steroidal inhibitors of ovulation. II. Metabolism of radioactive testosterone and dehydroepiandrosterone sulfate in subjects treated with lynestrenol, synthetic estrogens and their combination].
    Mauvais-Jarvis P
    Acta Endocrinol (Copenh); 1966 Sep; 53(1):37-52. PubMed ID: 4225012
    [No Abstract]   [Full Text] [Related]  

  • 36. [Contraceptive tablets and breast feeding].
    Sandholm LE; Borglin NE
    Nord Med; 1970 Dec; 84(50):1605-6. PubMed ID: 4933261
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral anticonception. Side effects and risks.
    Ostergaard E
    Acta Obstet Gynecol Scand; 1969; 48(S1):57-72. PubMed ID: 4244680
    [No Abstract]   [Full Text] [Related]  

  • 38. [A new estrogen variant in the oral contraceptive Non-Ovlon].
    Sarembe B
    Dtsch Gesundheitsw; 1973; 28(5):223-7. PubMed ID: 4579102
    [No Abstract]   [Full Text] [Related]  

  • 39. [Estrogens in contraception].
    Lauritzen C
    Wien Med Wochenschr; 1987 Oct; 137(18-19):427-32. PubMed ID: 3318154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Trial evaluation of the therapeutic value of the ovulation inhibitors in seborrhea and acne vulgaris].
    Aron-Brunetière R; Robin J
    Bull Soc Fr Dermatol Syphiligr; 1968; 75(1):47-51. PubMed ID: 4234130
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.